Constraints to counting bioluminescence producing cells by a commonly used transgene promoter and its implications for experimental design

por Mosaad, E. O., Futrega, K., Seim, I., Gloss, B., Chambers, K. F., Clements, J. A., Doran, M. R.
Publicado 2019

Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival

por Barton, C A, Gloss, B S, Qu, W, Statham, A L, Hacker, N F, Sutherland, R L, Clark, S J, O'Brien, P M
Publicado 2010

Intergenic disease-associated regions are abundant in novel transcripts

por Bartonicek, N., Clark, M. B., Quek, X. C., Torpy, J. R., Pritchard, A. L., Maag, J. L. V., Gloss, B. S., Crawford, J., Taft, R. J., Hayward, N. K., Montgomery, G. W., Mattick, J. S., Mercer, T. R., Dinger, M. E.
Publicado 2017

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

por O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, D I, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L
Publicado 2008

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

por O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Murali, R, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, Di, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L
Publicado 2008